Does NINTEDANIB Cause Pulmonary fibrosis? 316 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 316 reports of Pulmonary fibrosis have been filed in association with NINTEDANIB. This represents 1.2% of all adverse event reports for NINTEDANIB.
316
Reports of Pulmonary fibrosis with NINTEDANIB
1.2%
of all NINTEDANIB reports
127
Deaths
117
Hospitalizations
How Dangerous Is Pulmonary fibrosis From NINTEDANIB?
Of the 316 reports, 127 (40.2%) resulted in death, 117 (37.0%) required hospitalization, and 11 (3.5%) were considered life-threatening.
Is Pulmonary fibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NINTEDANIB. However, 316 reports have been filed with the FAERS database.
What Other Side Effects Does NINTEDANIB Cause?
Diarrhoea (9,103)
Nausea (4,198)
Dyspnoea (3,080)
Decreased appetite (2,832)
Death (2,790)
Weight decreased (2,628)
Vomiting (2,524)
Fatigue (2,511)
Cough (2,193)
Idiopathic pulmonary fibrosis (1,905)
What Other Drugs Cause Pulmonary fibrosis?
METHOTREXATE (2,912)
ADALIMUMAB (2,277)
RITUXIMAB (2,192)
ETANERCEPT (1,926)
TOCILIZUMAB (1,886)
ABATACEPT (1,828)
HYDROXYCHLOROQUINE (1,740)
LEFLUNOMIDE (1,731)
PREDNISONE (1,692)
INFLIXIMAB (1,595)
Which NINTEDANIB Alternatives Have Lower Pulmonary fibrosis Risk?
NINTEDANIB vs NINTEDANIB ESYLATE
NINTEDANIB vs NIRAPARIB
NINTEDANIB vs NIRMATRELVIR\RITONAVIR
NINTEDANIB vs NIROGACESTAT
NINTEDANIB vs NIROGACESTAT HYDROBROMIDE